These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24119958)

  • 1. [Importance of clinical trial design and standardized implementation in ophthalmology].
    Xu X
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):481-3. PubMed ID: 24119958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GCP data quality for early clinical development.
    Rock EP; Molloy VJ; Humphrey JS
    Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does the evidence tell us about design of future treatment trials for whiplash-associated disorders?
    Goldsmith CH; Gross AR; MacDermid J; Santaguida PL; Miller J
    Spine (Phila Pa 1976); 2011 Dec; 36(25 Suppl):S292-302. PubMed ID: 22020597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bias in surgical research.
    Paradis C
    Ann Surg; 2008 Aug; 248(2):180-8. PubMed ID: 18650626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Researchers facing increasing costs for clinical research, with few solutions.
    Erdmann J
    J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to special issue of Accountability in Research on the review and approval of biomedical research proposals: a call for a centralized national human research protections system.
    Mann H; Shamoo AE
    Account Res; 2006; 13(1):1-9. PubMed ID: 16770856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How evidence-based are publications in clinical ophthalmic journals?
    Lai TY; Leung GM; Wong VW; Lam RF; Cheng AC; Lam DS
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1831-8. PubMed ID: 16638988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Innovation and application are vital for translational research in ophthalmology].
    Du HJ; Zhang K; Hui YN
    Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):583-6. PubMed ID: 22943860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protecting the scientific integrity of a clinical trial: some ethical dilemmas.
    Howard J; Friedman L
    Clin Pharmacol Ther; 1981 May; 29(5):561-9. PubMed ID: 7214785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a checklist of quality indicators for clinical trials in resource-limited countries: the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience.
    Hanna M; Minga A; Fao P; Borand L; Diouf A; Mben JM; Gad RR; Anglaret X; Bazin B; Chene G;
    Clin Trials; 2013 Apr; 10(2):300-18. PubMed ID: 23345311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worrisome ailment in medicine: misleading journal articles; editors demand more data to ensure full disclosure of drug risks, trial gaps; Sarbanes-Oxley for professors.
    Mathews AW
    Wall St J (East Ed); 2005 May; ():A1, A9. PubMed ID: 15966125
    [No Abstract]   [Full Text] [Related]  

  • 17. SOP 02: Evaluation and selection of a clinical trial proposal for CESAR.
    Onkologie; 2003 Oct; 26 Suppl 6():5-10. PubMed ID: 23570178
    [No Abstract]   [Full Text] [Related]  

  • 18. Scientific and ethical considerations in trial design for investigational agents for the treatment of human immunodeficiency virus infection.
    Feinberg J; Japour AJ
    Clin Infect Dis; 2003 Jan; 36(2):201-6. PubMed ID: 12522753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific misconduct in investigational drug trials.
    Shapiro MF; Charrow RP
    N Engl J Med; 1985 Mar; 312(11):731-6. PubMed ID: 3974649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.